Exascale Labs FY2026 revenue rises 111% to $14.8 million; net loss $12.2 million
Exascale Labs reported fiscal 2026 revenue of $14.8 million, up 111% from $7.0 million, but its net loss widened to $12.2 million from $7.7 million. The loss increase reflects higher operating expenses and a $7.4 million non-cash fair value change on simple agreements for future equity (SAFEs), which converted into Class A common stock when the Nasdaq business combination closed on August 27, 2026, eliminating a $29.1 million liability.
Key points
- Revenue was $14.8 million versus $7.0 million; revenue from the intelligent computing power service rose 124.0%.
- Net loss was $12.2 million versus $7.7 million, including a $7.4 million change in fair value of SAFEs.
- Operating expenses rose to $7.2 million from $4.2 million; gross margin was 16.3% versus 15.8%.
- Business combination closed August 27, 2026, with approximately $11.8 million in net cash proceeds; shares began trading on Nasdaq as XLAB on August 28, 2026.
The filing
Written by AI on Nov 9, 2026, 11:48 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 28, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.